Suppr超能文献

相似文献

1
Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.
Infect Immun. 2007 May;75(5):2214-24. doi: 10.1128/IAI.01282-06. Epub 2007 Jan 29.
3
Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
Curr Top Microbiol Immunol. 2013;358:91-118. doi: 10.1007/82_2011_199.
5
Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.
Respirology. 2010 Aug;15(6):923-9. doi: 10.1111/j.1440-1843.2010.01792.x. Epub 2010 Jun 21.
6
Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
Am J Respir Crit Care Med. 2009 Jul 15;180(2):138-45. doi: 10.1164/rccm.200812-1943OC. Epub 2009 May 7.
8
Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs.
Environ Microbiol. 2011 Jul;13(7):1690-704. doi: 10.1111/j.1462-2920.2011.02483.x. Epub 2011 Apr 14.

引用本文的文献

2
Co-culture biofilm patterns among different Pseudomonas aeruginosa clones from cystic fibrosis patients.
Biofilm. 2025 Jan 25;9:100257. doi: 10.1016/j.bioflm.2025.100257. eCollection 2025 Jun.
3
Foodborne Infections and : Current Primary Prevention Tools and Future Perspectives.
Vaccines (Basel). 2024 Dec 31;13(1):29. doi: 10.3390/vaccines13010029.
5
Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions.
J Antimicrob Chemother. 2025 Feb 3;80(2):372-380. doi: 10.1093/jac/dkae413.
7
Development of a nano-emulsion based multivalent protein subunit vaccine against .
Front Immunol. 2024 Apr 18;15:1372349. doi: 10.3389/fimmu.2024.1372349. eCollection 2024.
8
Long-term evolution of antibiotic tolerance in lung infections.
Evol Lett. 2023 Sep 20;7(6):389-400. doi: 10.1093/evlett/qrad034. eCollection 2023 Dec.
10
natural history and evolution in the airways of adults with cystic fibrosis.
Front Microbiol. 2023 Jun 15;14:1205389. doi: 10.3389/fmicb.2023.1205389. eCollection 2023.

本文引用的文献

1
An Organ-Specific Differentiation Gene, pha-1, from Caenorhabditis elegans.
Science. 1990 Nov 2;250(4981):686-8. doi: 10.1126/science.250.4981.686.
2
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8487-92. doi: 10.1073/pnas.0602138103. Epub 2006 May 10.
3
Caenorhabditis elegans is a model host for Listeria monocytogenes.
Appl Environ Microbiol. 2006 Feb;72(2):1700-1. doi: 10.1128/AEM.72.2.1700-1701.2006.
5
Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
J Clin Microbiol. 2005 Oct;43(10):5247-55. doi: 10.1128/JCM.43.10.5247-5255.2005.
6
Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Eur Respir J. 2005 Sep;26(3):458-61. doi: 10.1183/09031936.05.00009605.
7
8
Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis.
Infect Immun. 2005 Apr;73(4):2504-14. doi: 10.1128/IAI.73.4.2504-2514.2005.
9
Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units.
Eur Respir J. 2004 Jul;24(1):101-6. doi: 10.1183/09031936.04.00122903.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验